• 24 million

    patients were treated with Roche medicines in 2024

  • 30 billion

    patients were treated with Roche medicines in 2024

  • + 1 %

    patients were treated with Roche medicines in 2024

Our two divisions are focusing jointly on three disease areas that will account for almost 50% of the global disease burden by 2035: cancer, cardiovascular-metabolic diseases and neurological diseases.
  • Dr Thomas Schinecker
  • CEO Roche Group

Investor Information

Monday, April 6, 2026
Updated 4:00PM ET

Last Price

127.74

Change

.36
View all Investor Information

Careers at Illumina

At Illumina, we push boundaries. We think beyond the conventional. We dream big. With the energy of so many bright and accomplished people, the opportunities are endless.
Search for Jobs

Press Contacts

if you are a member of the media:

if you are a member of the media, please visit Contact Us.

0.103759s